193 related articles for article (PubMed ID: 6130675)
1. Pharmacokinetic aspects of some beta-adrenoceptor blocking drugs.
Regårdh CG
Acta Med Scand Suppl; 1982; 665():49-60. PubMed ID: 6130675
[No Abstract] [Full Text] [Related]
2. Clinical pharmacokinetics of beta-adrenoreceptor blocking drugs.
Johnsson G; Regàrdh CG
Clin Pharmacokinet; 1976; 1(4):233-63. PubMed ID: 13958
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic comparison of beta-adrenoceptor blocking agents.
Kiechel JR; Meier J
Clin Invest Med; 1978; 1(3-4):135-8. PubMed ID: 42503
[No Abstract] [Full Text] [Related]
4. Clinical pharmacokinetics of prazosin--1985.
Vincent J; Meredith PA; Reid JL; Elliott HL; Rubin PC
Clin Pharmacokinet; 1985; 10(2):144-54. PubMed ID: 3888489
[TBL] [Abstract][Full Text] [Related]
5. Altered pharmacokinetics of beta-adrenoceptor blocking drugs in patients with renal insufficiency.
Tjandramaga TB
Arch Int Pharmacodyn Ther; 1980; Suppl():38-53. PubMed ID: 6106457
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic properties of the beta-adrenergic receptor blocking drugs.
Shand DG
Drugs; 1974; 7(1):39-47. PubMed ID: 4151694
[No Abstract] [Full Text] [Related]
7. Clinical pharmacokinetics of valproic acid.
Gugler R; von Unruh GE
Clin Pharmacokinet; 1980; 5(1):67-83. PubMed ID: 6767575
[No Abstract] [Full Text] [Related]
8. Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 1. Pharmacodynamic and pharmacokinetic properties.
Frishman W
Am Heart J; 1979 May; 97(5):663-70. PubMed ID: 34989
[No Abstract] [Full Text] [Related]
9. [Pharmacokinetics of antihypertensive drugs in kidney and liver diseases].
Knauf H; Mutschler E
MMW Munch Med Wochenschr; 1983 Nov; 125(45):1037-40. PubMed ID: 6139750
[No Abstract] [Full Text] [Related]
10. [Clinical pharmacology of beta-adrenoceptor blocking drugs and therapeutic use in hypertension (author's transl)].
Ebihara A
Nihon Naika Gakkai Zasshi; 1980 Mar; 69(3):297-312. PubMed ID: 6103912
[No Abstract] [Full Text] [Related]
11. The pharmacokinetic properties of beta adrenoceptor blocking drugs.
Gugler R
Arch Int Pharmacodyn Ther; 1980; Suppl():27-31. PubMed ID: 6106455
[No Abstract] [Full Text] [Related]
12. The clinical pharmacology of antiepileptic drugs.
Bruni J; Albright PS
Clin Neuropharmacol; 1984; 7(1):1-34. PubMed ID: 6423279
[No Abstract] [Full Text] [Related]
13. Disposition, metabolism and pharmacokinetics of antihyperlipidemic agents in laboratory animals and man.
Cayen MN
Pharmacol Ther; 1985; 29(2):157-204. PubMed ID: 3915091
[No Abstract] [Full Text] [Related]
14. Current status of labetalol, the first alpha- and beta-blocking agent.
Kanto JH
Int J Clin Pharmacol Ther Toxicol; 1985 Nov; 23(11):617-28. PubMed ID: 2867049
[TBL] [Abstract][Full Text] [Related]
15. Clinical pharmacokinetics of diazepam.
Mandelli M; Tognoni G; Garattini S
Clin Pharmacokinet; 1978; 3(1):72-91. PubMed ID: 346285
[TBL] [Abstract][Full Text] [Related]
16. Pharmacology of combined alpha-beta-blockade. I.
Louis WJ; McNeil JJ; Drummer OH
Drugs; 1984; 28 Suppl 2():16-34. PubMed ID: 6151889
[TBL] [Abstract][Full Text] [Related]
17. Drug interactions.
Rowland M
Adv Biol Skin; 1972; 12():235-55. PubMed ID: 4579195
[No Abstract] [Full Text] [Related]
18. Update of cardiovascular drug interactions.
Brater DC; Vasko MR
Prog Drug Res; 1985; 29():9-47. PubMed ID: 3911265
[No Abstract] [Full Text] [Related]
19. Clinical pharmacokinetics of the salicylates.
Needs CJ; Brooks PM
Clin Pharmacokinet; 1985; 10(2):164-77. PubMed ID: 3888490
[TBL] [Abstract][Full Text] [Related]
20. Clinical pharmacokinetics of sulphonylurea hypoglycaemic drugs.
Balant L
Clin Pharmacokinet; 1981; 6(3):215-41. PubMed ID: 7016385
[No Abstract] [Full Text] [Related]
[Next] [New Search]
